{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:00:18Z","timestamp":1790784018965,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T00:00:00Z","timestamp":1426464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T00:00:00Z","timestamp":1426464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/cmi.2015.13","type":"journal-article","created":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T09:34:19Z","timestamp":1426498459000},"page":"379-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL\/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation"],"prefix":"10.1038","volume":"13","author":[{"given":"Yanwei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zemin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,16]]},"reference":[{"key":"BFcmi201513_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0065-2776(08)60342-9","volume":"37","author":"AN Theofilopoulos","year":"1985","unstructured":"Theofilopoulos AN, Dixon FJ . Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37: 269\u2013390.","journal-title":"Adv Immunol"},{"key":"BFcmi201513_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1074-7613(02)00335-7","volume":"17","author":"AL Shaffer","year":"2002","unstructured":"Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002; 17: 51\u201362.","journal-title":"Immunity"},{"key":"BFcmi201513_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","volume":"13","author":"AL Shaffer","year":"2000","unstructured":"Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM . BCL-6 Represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 2000; 13: 199\u2013212.","journal-title":"Immunity"},{"key":"BFcmi201513_CR4","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271\u20131277.","journal-title":"Arthritis Rheum"},{"key":"BFcmi201513_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/jcp.53.6.424","volume":"53","author":"W Egner","year":"2000","unstructured":"Egner W . The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 2000; 53: 424\u2013432.","journal-title":"J Clin Pathol"},{"key":"BFcmi201513_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/08916930400024612","volume":"38","author":"Y Muro","year":"2005","unstructured":"Muro Y . Antinuclear antibodies. Autoimmunity 2005; 38: 3\u20139.","journal-title":"Autoimmunity"},{"key":"BFcmi201513_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cmi.2012.61","volume":"10","author":"Z Hua","year":"2012","unstructured":"Hua Z, Hou B . TLR signaling in B-cell development and activation. Cell Mol Immunol 2012; 10: 103\u2013106.","journal-title":"Cell Mol Immunol"},{"key":"BFcmi201513_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/416603a","volume":"416","author":"EA Leadbetter","year":"2002","unstructured":"Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A . Chromatin\u2013IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002; 416: 603\u2013607.","journal-title":"Nature"},{"key":"BFcmi201513_CR9","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1084\/jem.20050630","volume":"202","author":"CM Lau","year":"2005","unstructured":"Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, Mamula MJ et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/Toll-like receptor 7 engagement. J Exp Med 2005; 202: 1171\u20131177.","journal-title":"J Exp Med"},{"key":"BFcmi201513_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.immuni.2012.11.017","volume":"38","author":"LL Teichmann","year":"2013","unstructured":"Teichmann LL, Schenten D, Medzhitov R, Kashgarian M, Shlomchik MJ . Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity 2013; 38: 528\u2013540.","journal-title":"Immunity"},{"key":"BFcmi201513_CR11","first-page":"281","volume":"8","author":"E Robak","year":"1997","unstructured":"Robak E, Sysa-Jedrzejowska A, Stepien H, Robak T . Circulating interleukin-6 type cytokines in patients with systemic lupus erythematosus. Eur Cytokine Network 1997; 8: 281\u2013286.","journal-title":"Eur Cytokine Network"},{"key":"BFcmi201513_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1084\/jem.181.3.839","volume":"181","author":"L Llorente","year":"1995","unstructured":"Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995; 181: 839\u2013844.","journal-title":"J Exp Med"},{"key":"BFcmi201513_CR13","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.4049\/jimmunol.178.6.3822","volume":"178","author":"D Herber","year":"2007","unstructured":"Herber D, Brown TP, Liang S, Young DA, Collins M, Dunussi-Joannopoulos K . IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R. Fc reduces disease progression. J Immunol 2007; 178: 3822\u20133830.","journal-title":"J Immunol"},{"key":"BFcmi201513_CR14","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.4049\/jimmunol.173.9.5361","volume":"173","author":"K Ozaki","year":"2004","unstructured":"Ozaki K, Spolski R, Ettinger R, Kim HP, Wang G, Qi CF et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 2004; 173: 5361\u20135371.","journal-title":"J Immunol"},{"key":"BFcmi201513_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/cmi.2014.58","volume":"21","author":"XM Deng","year":"2015","unstructured":"Deng XM, Yan SX, Wei W . IL-21 acts as a promising therapeutic target in systemic lupus erythematosus by regulating plasma cell differentiation. Cell Mol Immunol 2015; 21: 31\u201339.","journal-title":"Cell Mol Immunol"},{"key":"BFcmi201513_CR16","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.4049\/jimmunol.1003871","volume":"188","author":"AL Rankin","year":"2012","unstructured":"Rankin AL, Guay H, Herber D, Bertino SA, Duzanski TA, Carrier Y et al. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL\/MpJ-Faslpr\/lpr\/J mice. J Immunol 2012; 188: 1656\u20131667.","journal-title":"J Immunol"},{"key":"BFcmi201513_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10875-007-9104-0","volume":"27","author":"HY Chun","year":"2007","unstructured":"Chun HY, Chung JW, Kim HA, Yun JM, Jeon JY, Ye YM et al. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol 2007; 27: 461\u2013466.","journal-title":"J Clin Immunol"},{"key":"BFcmi201513_CR18","first-page":"169","volume":"22","author":"L Lu","year":"2002","unstructured":"Lu L . [Study on effect of Cordyceps sinensis and artemisinin in preventing recurrence of lupus nephritis]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002; 22: 169\u2013171. Chinese.","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"BFcmi201513_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/cmi.2009.58","volume":"6","author":"O Jin","year":"2009","unstructured":"Jin O, Zhang H, Gu Z, Zhao S, Xu T, Zhou K et al. A pilot study of the therapeutic efficacy and mechanism of artesunate in the MRL\/lpr murine model of systemic lupus erythematosus. Cell Mol Immunol 2009; 6: 461\u2013467.","journal-title":"Cell Mol Immunol"},{"key":"BFcmi201513_CR20","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/abbs\/gmq101","volume":"42","author":"X Wu","year":"2010","unstructured":"Wu X, Zhang W, Shi X, An P, Sun W, Wang Z . Therapeutic effect of artemisinin on lupus nephritis mice and its mechanisms. Acta Biochim Biophys Sin 2010; 42: 916\u2013923.","journal-title":"Acta Biochim Biophys Sin"},{"key":"BFcmi201513_CR21","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.intimp.2009.09.003","volume":"9","author":"LF Hou","year":"2009","unstructured":"Hou LF, He SJ, Wang JX, Yang Y, Zhu FH, Zhou Y et al. SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo. Int Immunopharmacol 2009; 9: 1509\u20131517.","journal-title":"Int Immunopharmacol"},{"key":"BFcmi201513_CR22","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1002\/art.30392","volume":"63","author":"LF Hou","year":"2011","unstructured":"Hou LF, He SJ, Li X, Yang Y, He PL, Zhou Y et al. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL\/lpr mice by inhibiting Th1 and Th17 cell responses. Arthritis Rheum 2011; 63: 2445\u20132455.","journal-title":"Arthritis Rheum"},{"key":"BFcmi201513_CR23","doi-asserted-by":"publisher","first-page":"e32424","DOI":"10.1371\/journal.pone.0032424","volume":"7","author":"LF Hou","year":"2012","unstructured":"Hou LF, He SJ, Li X, Wan CP, Yang Y, Zhang XH et al. SM934 treated lupus-prone NZB\u00d7NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development. PLoS One 2012; 7: e32424.","journal-title":"PLoS One"},{"key":"BFcmi201513_CR24","unstructured":"Monahan E, Yamazaki K . An improved urine collection technique for laboratory mice: the bladder massage method. Lab Animal (USA) 1993; 38\u201339."},{"key":"BFcmi201513_CR25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0022-2143(99)90171-3","volume":"134","author":"LY Yang","year":"1999","unstructured":"Yang LY, Chen A, Kuo YC, Lin CY . Efficacy of a pure compound H1-A extracted from Cordyceps sinensis on autoimmune disease of MRL lpr\/lpr mice. J Lab Clin Med 1999; 134: 492\u2013500.","journal-title":"J Lab Clin Med"},{"key":"BFcmi201513_CR26","doi-asserted-by":"publisher","first-page":"R24","DOI":"10.1186\/ar1879","volume":"8","author":"X Tao","year":"2006","unstructured":"Tao X, Fan F, Hoffmann V, Longo NS, Lipsky PE . Therapeutic impact of the ethyl acetate extract of Tripterygium wilfordii Hook F on nephritis in NZB\/W F1 mice. Arthritis Res Ther 2006; 8: R24.","journal-title":"Arthritis Res Ther"},{"key":"BFcmi201513_CR27","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/art.23513","volume":"58","author":"X Tao","year":"2008","unstructured":"Tao X, Fan F, Hoffmann V, Gao CY, Longo NS, Zerfas P et al. Effective therapy for nephritis in (NZB\u00d7NZW) F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook F. Arthritis Rheum 2008; 58: 1774\u20131783.","journal-title":"Arthritis Rheum"},{"key":"BFcmi201513_CR28","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/art.23428","volume":"58","author":"FR Bahjat","year":"2008","unstructured":"Bahjat FR, Pine PR, Reitsma A, Cassafer G, Baluom M, Grillo S et al. An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus. Arthritis Rheum 2008; 58: 1433\u20131444.","journal-title":"Arthritis Rheum"},{"key":"BFcmi201513_CR29","first-page":"A1147","volume":"20","author":"X Tan","year":"2006","unstructured":"Tan X, Fan F, Hoffman V, Longo NS, Lipsky PE . Therapeutic impact of the ethyl acetate extract of Tripterygium wilfordii Hook F on nephritis in NZB\/W F1 mice. FASEB J 2006; 20: A1147.","journal-title":"FASEB J"},{"key":"BFcmi201513_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/aps.2013.167","volume":"35","author":"SJ He","year":"2014","unstructured":"He SJ, Lin ZM, Wu YW, Bai BX, Yang XQ, He PL et al. Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB\u00d7NZW F1 mice via interference with TLR-mediated APC response. Acta Pharmacol Sin 2014; 35: 219\u2013229.","journal-title":"Acta Pharmacol Sin"},{"key":"BFcmi201513_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3109\/08916930903374618","volume":"43","author":"AM Avalos","year":"2010","unstructured":"Avalos AM, Busconi L, Marshak-Rothstein A . Regulation of autoreactive B cell responses to endogenous TLR ligands. Autoimmunity 2010; 43: 76\u201383.","journal-title":"Autoimmunity"},{"key":"BFcmi201513_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","volume":"25","author":"SR Christensen","year":"2006","unstructured":"Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell Richard A, Shlomchik MJ . Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006; 25: 417\u2013428.","journal-title":"Immunity"},{"key":"BFcmi201513_CR33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri1957","volume":"6","author":"A Marshak-Rothstein","year":"2006","unstructured":"Marshak-Rothstein A . Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006; 6: 823\u2013835.","journal-title":"Nat Rev Immunol"},{"key":"BFcmi201513_CR34","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.4049\/jimmunol.165.10.5970","volume":"165","author":"M Odendahl","year":"2000","unstructured":"Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000; 165: 5970\u20135979.","journal-title":"J Immunol"},{"key":"BFcmi201513_CR35","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/art.22571","volume":"56","author":"A Sadanaga","year":"2007","unstructured":"Sadanaga A, Nakashima H, Akahoshi M, Masutani K, Miyake K, Igawa T et al. Protection against autoimmune nephritis in MyD88-deficient MRL\/lpr mice. Arthritis Rheum 2007; 56: 1618\u20131628.","journal-title":"Arthritis Rheum"},{"key":"BFcmi201513_CR36","first-page":"19","volume":"1","author":"L Xu","year":"2002","unstructured":"Xu L, Chen X, Tu Y . Efect of hydroartemisinin on lupus BXSB mice. Chin J Dermatovenerol Integr Tradit West Med 2002; 1: 19\u201320.","journal-title":"Chin J Dermatovenerol Integr Tradit West Med"},{"key":"BFcmi201513_CR37","doi-asserted-by":"publisher","first-page":"e104762","DOI":"10.1371\/journal.pone.0104762","volume":"9","author":"L Hou","year":"2014","unstructured":"Hou L, Block KE, Huang H . Artesunate abolishes germinal center B cells and inhibits autoimmune arthritis. PLoS One 2014; 9: e104762.","journal-title":"PLoS One"},{"key":"BFcmi201513_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.molmed.2003.11.004","volume":"10","author":"HJ Ditzel","year":"2004","unstructured":"Ditzel HJ . The K\/BxN mouse: a model of human inflammatory arthritis. Trends Mol Med 2004; 10: 40\u201345.","journal-title":"Trends Mol Med"},{"key":"BFcmi201513_CR39","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1126\/science.1073924","volume":"297","author":"J William","year":"2002","unstructured":"William J, Euler C, Christensen S, Shlomchik MJ . Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 2002; 297: 2066\u20132070.","journal-title":"Science"},{"key":"BFcmi201513_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0014-5793(03)00905-0","volume":"552","author":"E Aldieri","year":"2003","unstructured":"Aldieri E, Atragene D, Bergandi L, Riganti C, Costamagna C, Bosia A et al. Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-\u03baB activation. FEBS Lett 2003; 552: 141\u2013144.","journal-title":"FEBS Lett"},{"key":"BFcmi201513_CR41","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.intimp.2006.03.004","volume":"6","author":"WD Li","year":"2006","unstructured":"Li WD, Dong YJ, Tu YY, Lin ZB . Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation. Int Immunopharmacol 2006; 6: 1243\u20131250.","journal-title":"Int Immunopharmacol"},{"key":"BFcmi201513_CR42","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.4049\/jimmunol.167.4.2361","volume":"167","author":"E Arce","year":"2001","unstructured":"Arce E, Jackson DG, Gill MA, Bennett LB, Banchereau J, Pascual V . Increased frequency of pre-germinal center b cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol 2001; 167: 2361\u20132369.","journal-title":"J Immunol"},{"key":"BFcmi201513_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1749-6632.2003.tb06031.x","volume":"987","author":"MJ Shlomchik","year":"2003","unstructured":"Shlomchik MJ, Euler CW, Christensen SC, William J . Activation of rheumatoid factor (RF) B cells and somatic hypermutation outside of germinal centers in autoimmune-prone MRL\/lpr mice. Ann NY Acad Sci 2003; 987: 38\u201350.","journal-title":"Ann NY Acad Sci"},{"key":"BFcmi201513_CR44","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.4049\/jimmunol.174.11.6879","volume":"174","author":"J William","year":"2005","unstructured":"William J, Euler C, Shlomchik MJ . Short-lived plasmablasts dominate the early spontaneous rheumatoid factor response: differentiation pathways, hypermutating cell types, and affinity maturation outside the germinal center. J Immunol 2005; 174: 6879\u20136887.","journal-title":"J Immunol"},{"key":"BFcmi201513_CR45","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A . Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683\u2013765.","journal-title":"Annu Rev Immunol"},{"key":"BFcmi201513_CR46","first-page":"565","volume":"18","author":"G Gr\u00f6ndal","year":"1999","unstructured":"Gr\u00f6ndal G, Gunnarsson I, R\u00f6nnelid J, Rogberg S, Klareskog L, Lundberg I . Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 1999; 18: 565\u2013570.","journal-title":"Clin Exp Rheumatol"},{"key":"BFcmi201513_CR47","first-page":"283","volume":"16","author":"Y Park","year":"1997","unstructured":"Park Y, Lee S, Kim D, Lee J, Lee C, Song C . Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 1997; 16: 283\u2013288.","journal-title":"Clin Exp Rheumatol"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cmi201513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201513","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T11:06:28Z","timestamp":1672743988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi201513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,16]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["BFcmi201513"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2015.13","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,16]]},"assertion":[{"value":"4 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}